Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

71.52
Delayed Data
As of Aug 23
 -0.23 / -0.32%
Today’s Change
55.06
Today|||52-Week Range
75.04
+14.21%
Year-to-Date

Today’s Trading

Previous close71.75
Today’s open71.29
Day’s range71.27 - 71.90
Volume3,071,296
Average volume (3 months)5,353,459
Market cap$114.4B
Dividend yield3.58%
Data as of 08/23/2017

Growth & Valuation

Earnings growth (last year)+15.97%
Earnings growth (this year)+14.62%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+12.16%
P/E ratio17.6
Price/Sales3.98
Price/Book24.65

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.22-0.45%
CELGCelgene-1.10-0.84%
GSKGlaxoSmithKline+0.19+0.49%
BMYBristol-Myers Squibb+0.20+0.35%
Data as of 08/23/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)$1.38
Annual revenue (last year)$25.6B
Annual profit (last year)$5.9B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts